Does PEMBROLIZUMAB Cause Ventricular dysfunction? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Ventricular dysfunction have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.0% of all adverse event reports for PEMBROLIZUMAB.
17
Reports of Ventricular dysfunction with PEMBROLIZUMAB
0.0%
of all PEMBROLIZUMAB reports
1
Deaths
6
Hospitalizations
How Dangerous Is Ventricular dysfunction From PEMBROLIZUMAB?
Of the 17 reports, 1 (5.9%) resulted in death, 6 (35.3%) required hospitalization.
Is Ventricular dysfunction Listed in the Official Label?
Yes, Ventricular dysfunction is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Ventricular dysfunction?
DOXORUBICIN (140)
CYCLOPHOSPHAMIDE (98)
TRASTUZUMAB (70)
VINCRISTINE (60)
RITUXIMAB (53)
FUROSEMIDE (51)
EPIRUBICIN (45)
RAMIPRIL (45)
BISOPROLOL (43)
OMEPRAZOLE (42)
Which PEMBROLIZUMAB Alternatives Have Lower Ventricular dysfunction Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G